A randomized, placebo-controlled, double-blind trial of augmentation of clozapine with risperidone

被引：0
|
作者：
Honer, W [1 ]
MacEwan, GW [1 ]
Williams, R [1 ]
Falkai, P [1 ]
McKenna, PJ [1 ]
Pomarol-Clotet, E [1 ]
Chen, EY [1 ]
Leung, SP [1 ]
Wong, J [1 ]
Stip, E [1 ]
机构：
[1] Univ British Columbia, Ctr Complex Disorders, Vancouver, BC V5Z 1M9, Canada
来源：
SCHIZOPHRENIA BULLETIN | 2005年 / 31卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：487 / 487
页数：1
相关论文
共 50 条
  • [31] Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial
    Pandina, Gahan J.
    Canuso, Carla M.
    Turkoz, Ibrahim
    Kujawa, Mary
    Mahmoud, Ramy A.
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 2007, 40 (03) : 41 - 57
  • [32] Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
    Mahtab Asadabadi
    Mohammad-Reza Mohammadi
    Ahmad Ghanizadeh
    Amirhossein Modabbernia
    Mandana Ashrafi
    Elmira Hassanzadeh
    Saeedeh Forghani
    Shahin Akhondzadeh
    [J]. Psychopharmacology, 2013, 225 : 51 - 59
  • [33] Pregnenolone as an adjunct to risperidone for treatment of women with schizophrenia: A randomized double-blind placebo-controlled clinical trial
    Kashani, Ladan
    Shams, Nazila
    Moazen-Zadeh, Ehsan
    Karkhaneh-Yousefi, Mohammad-Ali
    Sadighi, Gita
    Khodaie-Ardakani, Mohammad-Reza
    Rezaei, Farzin
    Rahiminejad, Fatemeh
    Akhondzadeh, Shahin
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 94 : 70 - 77
  • [34] The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial
    Abbasi, Seyed-Hesameddin
    Behpournia, Haleh
    Ghoreshi, Aboulfazl
    Salehi, Bahman
    Raznahan, Maedeh
    Rezazadeh, Shams-Ali
    Rezaei, Farzin
    Akhondzadeh, Shahin
    [J]. SCHIZOPHRENIA RESEARCH, 2010, 116 (2-3) : 101 - 106
  • [35] Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: An 8-week, randomized, double-blind, placebo-controlled trial
    Chang, Jae Seung
    Ahn, Yong Min
    Park, Hye Jean
    Lee, Kyu Young
    Kim, Se Hyun
    Kang, Ung Gu
    Kim, Yong Sik
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (05) : 720 - 731
  • [36] A randomized, double-blind, placebo-controlled trial: Paroxetine controlled release in fibromyalgia
    Patkar, AA
    Masand, PS
    Jiang, W
    Krulewicz, S
    Dube, E
    Purcell, C
    McMorran, C
    Peindl, K
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S319 - S320
  • [37] Topiramate Augmentation in Resistant OCD: A Double-Blind Placebo-Controlled Clinical Trial
    Mowla, Arash
    Khajeian, Abdol Mohammad
    Sahraian, Ali
    Chohedri, Abdol Hamid
    Kashkoli, Faramarz
    [J]. CNS SPECTRUMS, 2010, 15 (11) : 613 - 617
  • [38] Cognitive effects with rivastigmine augmentation of risperidone: A 12-month, randomized, double-blind, placebo-controlled study in schizophrenia
    Kumar, Pattath Narayanan Suresh
    Mohemmedali, Seema P.
    Anish, P. K.
    Andrade, Chittaranjan
    [J]. INDIAN JOURNAL OF PSYCHIATRY, 2017, 59 (02) : 219 - 224
  • [39] Short-term testosterone augmentation in male schizophrenics - A randomized, double-blind, placebo-controlled trial
    Ko, Young-Hoon
    Lew, Young-Min
    Jung, Sung-Won
    Joe, Sook-Haeng
    Lee, Chang-Hyun
    Jung, Hyun-Gang
    Lee, Moon-Soo
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (04) : 375 - 383
  • [40] Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial
    Afshar, Hamid
    Akuchekian, Shahla
    Mahaky, Behzad
    Zarean, Elham
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 (10): : 976 - 981
12345